In the present study, the primary AVF failure was
seen in 18.9% of the operations. Our study revealed
that patients with DM had a statistically significantly
higher ratio of primary AVF failure, but DM was not
an independent risk factor for AVF failure. Higher
levels of HbA1c failed to predict AVF failure.
A recent meta-analysis demonstrated a higher rate
of AVF failure in patients with diabetes,[10] which is
consistent with our study. Other than hyperglycemia
inducing vascular damage itself, metabolic changes
accompanying DM such as endothelial damage and
endothelial dysfunction impair venous remodeling and may result in failure to mature.[2,10] Besides,
DM is associated with an increased extracellular
matrix deposition, deregulated growth factors, and
pro-thrombotic activity and it is a known risk factor
for atherosclerosis, which all may promote AVF
failure.[11]
Our study demonstrated that preoperative levels
of HbA1c failed to be a predictor of AVF failure.
No consensus has been reached in the literature
on whether HbA1c level has an impact on AVF
failure. Some authors have advocated that HbA1c
≥7% is associated with higher rates of AVF failure or
lower patency rate,[12,13] whereas a recent prospective
study has shown that HbA1c level is not related
to delayed maturity.[14] Afsar and Elsurer[12] explain
their findings mainly based on the assumptions that
greater HbA1c levels indicate presence of DM and
that greater HbA1c levels suggest poor glycemic
control. The authors also suggested that peripheral
artery disease, which they found to be associated
with the increased HbA1c levels, might affect AVF
failure. Singh et al.[14] observed that those with HbA1c
<6.5% had higher rates of AVF maturity at six weeks
post-creation. Nevertheless, they demonstrated no
significant relationship between HbA1c status and
delayed maturity. Wu et al.[13] reported a direct effect
of hyperglycemia on endothelium, yet underlined their
apprehension on whether baseline glycemic status
could reflect the severity of underlying diabetes.
Hyperglycemia is known to create tendency to
thrombosis via blood flow retardation and platelet
aggregation,[10] which may eventually cause AVF
failure. Although recent guidelines recommend the
same target level of HbA1c for patients with and
without CKD, it is a matter of debate whether HbA1c
level predicts blood glucose control accurately in CKD
patients. It has been suggested by many authors that
the correlation between HbA1c and blood glucose
is impaired in CKD patients and that HbA1c may
not be a reliable indicator of blood glucose control in
these patients.[15,16] Reduced red blood cell survival
and common use of erythropoietin-stimulating agents
increase the rate of young erythrocytes in these
patients. These erythrocytes have less exposure time
to glucose, which affects HbA1c levels. Several studies
have indicated that the measured HbA1c levels of
diabetic CKD patients are lower than indicated by their
blood glucose levels, and thus HbA1c level mispresents
glycemic control.[15,17] Although it is beyond of our
scope to assess the predictive value of HbA1c level on blood glucose level in CKD patients, our analysis
revealed no significant correlation between blood
glucose levels and HbA1c levels in hemodialysis
patients with DM. Although hyperglycemia seems
to be an important parameter affecting AVF failure,
it may be misleading to assess HbA1c as an accurate
predictor of blood glucose control in CKD patients.
This may explain our finding that HbA1c level is not
associated with AVF failure.
Vascular hyperglycemic memory is a relatively
recent definition, describing the persistence of the
effects of hyperglycemic stress, even though the blood
glucose is normalized.[2] This phenomenon makes the
predictive value of the biochemical markers, which can
only suggest recent blood glucose control, on vascular
outcomes questionable, since recent blood glucose
normalization does not rule out previous long-term
hyperglycemia. Although the reliability of different
markers remains being a matter of debate, it seems
that any of these markers would be effective to predict
AVF failure.
In our study, lower levels of platelet count were
observed in patients with AVF failure. Although it is
beyond doubt that thrombosis plays a role in the failure
mechanism, an inverse association between platelet
count and AVF failure is unexpected. Future studies
should be made to analyze the effect of thrombosisrelated
parameters on AVF failure.
The single-center, retrospective design with a
relatively small sample size with AVF failure are the
main limitations of our study. Another limitation
is that no subgroup analysis was able to be made
considering AVF locations. The AVFs with different
arteries and veins may have different characteristics
which can affect AVF maturation and, thus, AVF
failure. However, our study includes only autogenous
AVFs, created by a single surgeon, eliminating the
effect of surgical approach on fistula failure. Besides,
we reviewed an adequate number of primary AVF
operations, suggesting that there is no predictive value
of preoperative HbA1c on primary AVF failure.
In conclusion, diabetes is associated with AVF
failure irrespective of the patients’ HbA1c levels.
Although hyperglycemia seems to play a role in
pathogenesis, there is a growing concern that HbA1c
level may not be accurately indicating blood glucose
control in CKD patients. In addition, considering that
biochemical markers fail to present previous long-term
hyperglycemia, predictive value of these markers on vascular outcomes is limited. Based on these findings,
the role of preoperative HbA1c is limited in predicting
primary AVF failure.
Acknowledgements
We would like to thank Prof. Dr. Hasan Güçlü, from the
Department of Biostatistics, Faculty of Medicine, Istanbul
Medeniyet University for his valuable assistance in statistical
analysis.
Declaration of conflicting interests
The authors declared no conflicts of interest with respect
to the authorship and/or publication of this article.
Funding
The authors received no financial support for the research
and/or authorship of this article.